J.B. Chemicals & Pharmaceuticals Ltd. logo

J.B. Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM)

Market Closed
23 Jul, 10:00
XNSE XNSE
2,408. 90
0
0%
330.22B Market Cap
55.03 P/E Ratio
10.13% Div Yield
4.78M Volume
0 Eps
2,408.9
Previous Close
Add Transaction
Day Range
2,408.9 2,408.9
Year Range
1,638.5 2,525.5
Want to track JBCHEPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

JBCHEPHARM closed Thursday higher at ₹2,408.9, an increase of 0% from Wednesday's close, completing a monthly increase of 4.963% or ₹113.9. Over the past 12 months, JBCHEPHARM stock gained 31.7347%.
JBCHEPHARM pays dividends to its shareholders, with the most recent payment made on Feb 25, 2026. The next estimated payment will be in In 2 weeks on Aug 25, 2026 for a total of ₹12.7.
The last earnings report, released on May 21, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
J.B. Chemicals & Pharmaceuticals Ltd. has completed 2 stock splits, with the recent split occurring on Sep 18, 2023.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

JBCHEPHARM Chart

People also search for

Sun Pharmaceutical Industries Ltd.
1,944.4
-0.0308%
Tata Motors Ltd.
347.1
+0.0288%
Maruti Suzuki India Limited
14,097
+0.4274%
M&M
Mahindra & Mahindra Ltd.
3,517
+0.4283%
Bajaj Auto Limited
11,677
+0.1286%

J.B. Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) FAQ

What is the stock price today?

The current price is ₹2,408.90.

On which exchange is it traded?

J.B. Chemicals & Pharmaceuticals Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is JBCHEPHARM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 10.13%.

What is its market cap?

As of today, the market cap is 330.22B.

Has J.B. Chemicals & Pharmaceuticals Ltd. ever had a stock split?

J.B. Chemicals & Pharmaceuticals Ltd. had 2 splits and the recent split was on Sep 18, 2023.

J.B. Chemicals & Pharmaceuticals Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Nikhil Ashokkumar Chopra CEO
XNSE Exchange
Y4429Q142 CUSIP
IN Country
5,304 Employees
29 May 2026 Last Dividend
18 Sep 2023 Last Split
- IPO Date

Overview

J. B. Chemicals & Pharmaceuticals Limited is a significant player in the global pharmaceutical industry, with a strong presence both within India and internationally. Founded in 1976 and based out of Mumbai, India, the company specializes in the manufacture and marketing of an extensive range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). It caters to various therapeutic areas including gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, and more. Its services are not only limited to the production of pharmaceutical products but also extend to providing contract manufacturing services for a wide array of pharmaceutical dosage forms.

Products and Services

  • API Product Portfolio

    The company boasts a diverse API product portfolio comprising diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; along with ciprofloxacin, cetirizine, and meclizine HCI. These APIs serve as the primary ingredients in a wide range of pharmaceuticals, addressing various health conditions.

  • Contract Manufacturing Services

    J. B. Chemicals & Pharmaceuticals offers contract manufacturing services that span a multitude of pharmaceutical dosage forms, including tablets, lozenges, injectables, gels, creams, ointments, and liquid herbal syrups. The company is also adept at producing soft-centered, powder, medicated, and herbal lozenges, showcasing its versatility in pharmaceutical manufacturing.

  • Range of Contrast Media Products

    Another notable aspect of the company’s product line is its range of contrast media products, designed for use in various diagnostic procedures such as x-rays, magnetic resonance imaging (MRI), and ultrasounds. These products are essential in the diagnostic imaging sector, aiding in the accurate diagnosis of numerous medical conditions.

  • Expansive Therapeutic Coverage

    The company's products and services cover an expansive range of therapeutic areas. This includes, but is not limited to, gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, dental care, vitamins and minerals, hypertension, diabetes, nephrology, respiratory conditions, pain and analgesic care, dermatology, antivirals, and lozenges. By providing such a broad spectrum of healthcare solutions, J. B. Chemicals & Pharmaceuticals plays a pivotal role in enhancing patient care across various medical disciplines.

Contact Information

Address: Cnergy IT Park, Mumbai, India, 400025
Phone: 91 22 2439 5200